Pioneering cellular medicines for women’s health

We’re developing off-the-shelf cell therapies for high-impact women’s diseases, with lead programs in ovarian cancer, triple negative breast cancer and endometriosis.

Pioneering excellence in the field of immunotherapy

Cartherics creates precisely-defined immunotherapy treatments to combat a variety of cancers, endometriosis and Alzheimer’s disease. We combine the best components of immune targeting utilising gene editing and CAR technology to advance cell therapy to provide more diverse off-the-shelf treatments for patients. Our team has strong backgrounds in research, development, and product commercialisation. And we partner with leading commercial and academic groups with complementary technology to push the boundaries of cell therapy for cancer and beyond.

Learn more about us

Some of our partners

Latest news

The Fight Against Cancer Continues ……. Despite COVID-19

By Christine Filippis / November 18, 2020
18 November 2020 By Leigh Dayton They may not be able to gather at the Melbourne Convention Centre this year,...
Read More

Cartherics CEO handed the editorial chair

By Christine Filippis / November 9, 2020
Alan Trounson guest edits a special immunology issue of the journal Cells  By Leigh Dayton 9 Nov 2020   As well...
Read More

Nobel Chemistry prize going to CRISPR scientists

By Christine Filippis / October 9, 2020
Genetic scissors: a tool for rewriting the code of life wins the 2020 Nobel Prize for Chemistry Emmanuelle Charpentier and...
Read More